Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II

Journal of Immunology

Volumn 181, Issue 1, 2008, Pages 165-173

  Fehr, Thomas ^a,b   Haspot, Fabienne ^a   Mollov, Joshua ^a   Chittenden, Meredith ^a   Hogan, Timothy ^a   Sykes, Megan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; HLA ANTIGEN CLASS 2; INTERLEUKIN 2;

ALLOIMMUNITY; ANTIGEN FUNCTION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CHIMERA; DENDRITIC CELL; GRAFT RECIPIENT; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WHOLE BODY RADIATION; ALLOSTERISM; ANIMAL; DRUG EFFECT; FEMALE; IMMUNOLOGY; TIME; TRANSGENIC MOUSE;

ALLOSTERIC REGULATION; ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE TOLERANCE; INTERLEUKIN-2; MICE; MICE, TRANSGENIC; TIME FACTORS;

EID: 47949126592     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.1.165     Document Type: Article

References (47)

1. Kawai, T., A. B. Cosimi, T. R. Spitzer, N. Tolkoff-Rubin, M. Suthanthiran, S. L. Saidman, J. Shaffer, F. I. Preffer, R. Ding, V. Sharma, et al. 2008. HLA-mismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med. 358: 353-361.
2. Fudaba, Y., T. R. Spitzer, J. Shaffer, T. Kawai, T. Fehr, F. Delmonico, F. Preffer, N. Tolkoff-Rubin, B. R. Dey, S. L. Saidman, et al. 2006. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am. J. Transplant. 6: 2121-2133.
3. Fehr, T., and M. Sykes. 2004. Tolerance induction in clinical transplantation. Transpl. Immunol. 13: 117-130.
4. Sharabi, Y., D. H. Sachs, and M. Sykes. 1992. T cell subsets resisting induction of mixed chimerism across various histocompatibility barriers. In Progress in Immunology VIII: Proceedings of the Eighth International Congress of Immunology, August 23-28. J. Gergely, M. Benczur, A. Falus, G. Fust, G. Medgyesi, G. Petranyi, and E. Rajnavolgyi, eds. Springer-Verlag, Heidelberg, pp. 801-805.
5. Wekerle, T., M. H. Sayegh, J. Hill, Y. Zhao, A. Chandraker, K. G. Swenson, G. Zhao, and M.-Sykes. 1998. Extrathymic T cell deletion and allogeneic stem cell cngraftmcnt induced with costimulatory blockade is followed by central T cell tolerance. J. Exp. Med. 187: 2037-2044.
6. Sykes, M. 2001. Mixed chimerism and transplant tolerance. Immunity 14: 417-424.
7. Kurtz, J., J. Shaffer, A. Lie, N. Anosova, G. Benichou, and M. Sykes. 2004. Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD 154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells. Blood 103: 4336-4343.
8. + T cells, precluding a role for sustained regulation. Eur. J. Immunol. 35: 2679-2690.
9. Kurtz, J., T. Wekerle, and M. Sykes. 2004. Tolerance in mixed chimerism: a role for regulatory cells? Trends Immunol. 25: 518-523.
10. + T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40L. Am. J. Transplant. 4: 31-40.
11. + T cells in major histocompatibility complex class II-deficient mice. Science 253: 1417-1420.
12. Chang, C. H., S. Guerder, S. C. Hong, W. Van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4: 167-178.
13. + T cell repertoire and anti-Iymphocytic choriomeningitis virus cytolytic responses. Eur. J. Immunol. 29: 1243-1252.
14. + T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
15. Gould, D. S., and H. Auchincloss, Jr. 1999. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol. Today 20: 77-82.
16. Suchin, E. J., P. B. Langmuir, E. Palmer, M. H. Sayegh, A. D. Wells, and L. A. Turka. 2001. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166: 973-981.
17. Liu, Z., Y. K. Sun, Y. P. Xi, A, Maffei, E. Reed, P. Harris, and N. Suciu-Foca. 1993. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J. Exp. Med. 177: 1643-1650.
18. Sherwood, R. A., L. Brent, and L. S. Rayfield. 1986. Presentation of alloantigens by host cells. Eur. J. Immunol. 16: 569-574.
19. + cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation. Transplantation 60: 1621-1624.
20. Kishimoto, K-, X. Yuan, H. Auchincloss, Jr., A. H. Sharpe, D. A. Mandelbrot, and M. H. Sayegh. 2004. Mechanism of action of donor-specific transfusion in inducing tolerance: role of donor MHC molecules, donor co-stimulatory molecules, and indirect antigen presentation. J. Am. Soc. Nephrol. 15: 2423-2428.
21. Yamada, A., A. Chandraker, T. M. Laufer, A. J. Gerth, M. H. Sayegh, and H. Auchincloss, Jr. 2001. Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J. Immunol. 167: 5522-5526.
22. Rulifson, I. C., G. L. Szot, E. Palmer, and J. A. Bluestone. 2002. Inability to induce tolerance through direct antigen presentation. Am. J. Transplant. 2: 510-519.
23. + T cells. Am. J. Transplant. 7: 2269-2278.
24. Grossman, Z., and W. E. Paul. 1992. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc. Natl. Acad. Sci. USA 89: 10365-10369.
25. + T cells: evidence from a lymphopenic T cell model. Immunity 17: 425-436.
26. Dubois, B., B. Vanbervliet, J. Fayette, C. Massacrier, C. van Kooten, F. Briere, J. Banchcreau, and C. Caux. 1997. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185: 941-951.
27. Huang, N. N., S. B. Han, I. Y. Hwang, and J. H. Kehrl. 2005. B cells productively engage soluble antigen-pulsed dendritic cells: visualization of live-cell dynamics of B cell-dendritic cell interactions. J. Immunol. 175: 7125-7134.
28. +T-cell priming in vivo. Blood 107: 594-601.
29. Penna, G., S. Amuchastegui, N. Giarratana, K. C. Daniel, M. Vulcano, S. Sozzani, and L. Adorini. 2007. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J. Immunol. 178: 145-153.
30. + T regulatory cells and promote organ transplant tolerance. J. Immunol. 178: 7018-7031.
31. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
32. Rutella, S., S. Danese, and G. Leone. 2006. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108: 1435-1440.
33. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258: 1156-1159.
34. + T cells. J. Exp. Med. 188: 1977-1983.
35. Niimi, M" D. L. Roelen, W. Wong, M. Hara, P. J. Morris, and K. J. Wood. 1997. Resting B cells as tolerogens in vivo but only for minor histocompatibility antigens: evidence for activation of resting B cells in vivo. Transplantation 64: 1330-1335.
36. + T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J. Immunol. 178: 3447-3456.
37. Rowe, V., T. Banovic, K. P. MacDonald, R. Kuns, A. L. Don, E. S. Morris, A. C. Burman, H. M. Bofinger, A. D. Clouston, and G. R. Hill. 2006. Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation. Blood 108: 2485-2492.
38. Deng, S., D. J. Moore, X. Huang, M. M. Lian, M. Mohiuddin, E. Velededeoglu, M. K. Lee, S. Sonawane, J. Kim, J. Wang, et al. 2007. Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J. Immunol. 178: 6028-6032.
39. Deng, S., D. J. Moore, X. Huang, M. Mohiuddin, M. K. Lee, E. Velidedeoglu, M. M. Lian, M. Chiaccio, S. Sonawane, A. Orlin, et al. 2006. Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells. J. Immunol. 176: 2799-2807.
40. Mizoguchi, A., and A. K. Bhan. 2006. A case for regulatory B cells. J. Immunol. 176: 705-710.
41. + T cells: role of TGF-β1. J. Immunol. 170:5897-5911.
42. Smyth, L. A., O. B. Herrera, D. Golshayan, G. Lombardi, and R. I. Lechler. 2006. A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases. Transplantation 82: S15-S18.
43. Herrera, O. B., D. Golshayan, R. Tibbott, O. F. Salcido, M. J. James, F. M. Marelli-Berg, and R. I. Lechler. 2004. A novel pathway of alloantigen presentation by dendritic cells. J. Immunol. 173: 4828-4837.
44. + T cells. J. Immunol. 177: 6018-6024.
45. Sapoznikov, A., Y. Pewzner-Jung, V. Kalchenko, R. Krauthgamer, I. Shachar, and S. Jung. 2008. Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nat. Immunol. 9: 388-395.
46. Wells, A. D., M. C. Walsh, J. A. Bluestone, and L. A. Turka. 2001. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J. Clin. Invest. 108: 895-903.
47. Haspot, F., T. Fehr, C. Gibbons, G. Zhao, T. Hogan, T. Honjo, G. J. Freeman, and M. Sykes. 2008. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway. Blood, In press.